Medical Bulletin 18/November/2022 Dr. Nandita Mohan18 Nov 2022 1:00 PM ISTHere are the top medical news for the day:More cancers are diagnosed at an advanced stage if patients already have type 2 diabetesWe all are aware of...
FDA panel okays tenapanor as monotherapy for control of serum phosphorus in CKD patients on dialysis Dr. Kamal Kant Kohli18 Nov 2022 10:15 AM ISTUse of tenapanor (Xphozah®) as monotherapy for the control of serum phosphorus in adult patients with chronic kidney disease (CKD) on dialysis has...
Persistent hematuria associated with strong risks of chronic kidney disease Dr. Nandita Mohan18 Nov 2022 9:30 AM ISTHematuria, as we all know is characterized by the presence of blood in the urine, has been reported to be associated with increased risk of chronic...
Sudden Rise of Uric Acid Levels in a Patient with Chronic Kidney Disease: Is a Common Food to Blame? Dr. Nandita Mohan12 Nov 2022 9:15 AM ISTChronic kidney disease (CKD) is often characterized with slightly raised serum uric acid levels. Earlier, this urate level was thought to be an...
Long term exposure to air pollution increases risk of developing CKD Dr. Kamal Kant Kohli6 Nov 2022 7:00 PM ISTChronic kidney disease (CKD) is a global disease burden related to high rates of incidence and mortality. It manifests as progressive and...
Dapagliflozin effective from clinical standpoint as well as cost standpoint for CKD patients Dr. Kamal Kant Kohli5 Nov 2022 9:30 AM ISTThe burden of chronic kidney disease (CKD) to both healthcare systems and patients is considerable. Dapagliflozin, a sodium-glucose cotransporter-2...
Long-term exposure to air pollution can heighten kidney disease risk Isra Zaman5 Nov 2022 9:00 AM ISTAmong adults with normal kidney function, exposure to higher concentrations of components of air pollution was linked with higher risks of later...
Medical Bulletin 3/November/2022 Isra Zaman3 Nov 2022 11:26 AM ISTHere are the top medical news for the day:ACC, AHA guideline on the diagnosis and management of aortic diseaseThe aorta is the largest artery in the...
Dapagliflozin clinically and cost effective in patients with chronic kidney disease: DAPA-CKD trial Isra Zaman3 Nov 2022 9:15 AM IST A recent analysis in CJASN indicates that in patients eligible for the DAPA-CKD trial, dapagliflozin is not only effective from a clinical...
Clinicopathological Study of Chronic Kidney Disease of Unknown Etiology in Odisha Dr. Nandita Mohan18 Oct 2022 9:00 AM ISTChronic kidney disease (CKD) is a global burden and commonly characterized by traditional risk factors like diabetes, hypertension,...
CDSCO panel opines Paraxel to study either CKD or heart failure in phase IIb trial of AZD9977,Dapagliflozin FDC Susmita Roy25 Sept 2022 1:28 PM ISTNew Delhi: In line with Paraxel's clinical trial protocol to study efficacy and safety of AZD9977 in combination with dapagliflozin in patients with...
Is it really healthy to restrict protein intake for kidney transplant recipients? Dr. Kamal Kant Kohli23 Sept 2022 8:30 PM ISTChronic kidney disease patients are known to have induced sarcopenia due to chronic inflammation, hypercatabolism, decreased nutrient intake, and...
